It could cause you a lot of problems.

Bristol-Myers Squibb is upgraded to Buy as its growth portfolio now offsets legacy declines, validating a bullish contrarian ...

Ooops... Something went wrong while loading this page.

You spend countless hours optimizing your site for human visitors. Tweaking the hero image, testing button colors, and ...